RU2015142156A - Means for application anesthesia with antiseptic, opticokeratoprotective properties and method of its use in ophthalmology - Google Patents

Means for application anesthesia with antiseptic, opticokeratoprotective properties and method of its use in ophthalmology Download PDF

Info

Publication number
RU2015142156A
RU2015142156A RU2015142156A RU2015142156A RU2015142156A RU 2015142156 A RU2015142156 A RU 2015142156A RU 2015142156 A RU2015142156 A RU 2015142156A RU 2015142156 A RU2015142156 A RU 2015142156A RU 2015142156 A RU2015142156 A RU 2015142156A
Authority
RU
Russia
Prior art keywords
opticokeratoprotective
ophthalmology
antiseptic
properties
tool
Prior art date
Application number
RU2015142156A
Other languages
Russian (ru)
Other versions
RU2624901C2 (en
Inventor
Елизавета Геннадьевна Полунина
Вячеслав Владимирович Куренков
Сергей Игоревич Абрамов
Деян Йованович
Original Assignee
Елизавета Геннадьевна Полунина
Вячеслав Владимирович Куренков
Сергей Игоревич Абрамов
Деян Йованович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елизавета Геннадьевна Полунина, Вячеслав Владимирович Куренков, Сергей Игоревич Абрамов, Деян Йованович filed Critical Елизавета Геннадьевна Полунина
Priority to RU2015142156A priority Critical patent/RU2624901C2/en
Publication of RU2015142156A publication Critical patent/RU2015142156A/en
Application granted granted Critical
Publication of RU2624901C2 publication Critical patent/RU2624901C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (5)

1. Средство в виде геля для проведения аппликационной анестезии при офтальмологических вмешательствах, содержащее лидокаина гидрохлорид, хлоргексидина дигидрохлорид, гидроксиэтилцеллюлозу, глицерол, воду при следующем соотношении компонентов, мас.%:1. The tool in the form of a gel for application anesthesia for ophthalmic interventions containing lidocaine hydrochloride, chlorhexidine dihydrochloride, hydroxyethyl cellulose, glycerol, water in the following ratio, wt.%: ГидроксиэтилцеллюлозаHydroxyethyl cellulose 1,2-1,81.2-1.8 ГлицеролGlycerol 17-2517-25 Лидокаина гидрохлоридLidocaine hydrochloride 1,8-2,41.8-2.4 Хлоргексидина дигидрохлоридChlorhexidine dihydrochloride 0,03-0,070.03-0.07 ВодаWater Остальное до 100The rest is up to 100
2. Средство по п. 1, отличающееся тем, что средство наносят за нижнее веко до полного прикрытия им глазного яблока от наружной до внутренней спайки век.2. The tool according to claim 1, characterized in that the tool is applied beyond the lower eyelid until the eyeball is completely covered by it from the outer to the inner commissure of the eyelids. 3. Способ аппликационной анестезии при офтальмологических вмешательствах, включающий нанесение средства по п. 1 в конъюнктивальную полость оперируемого глаза за 15 мин до операции.3. A method of application anesthesia for ophthalmic interventions, comprising applying the agent according to claim 1 to the conjunctival cavity of the operated eye 15 minutes before surgery. 4. Способ по п. 3, отличающийся тем, что средство наносят за нижнее веко до полного прикрытия им глазного яблока от наружной до внутренней спайки век.4. The method according to p. 3, characterized in that the agent is applied beyond the lower eyelid until the eyeball is completely covered by it from the outer to the inner adhesion of the eyelids.
RU2015142156A 2015-10-05 2015-10-05 Agent for application anaesthesia with antiseptic, optical-keratoprotective properties and method for use thereof in ophthalmology RU2624901C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015142156A RU2624901C2 (en) 2015-10-05 2015-10-05 Agent for application anaesthesia with antiseptic, optical-keratoprotective properties and method for use thereof in ophthalmology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015142156A RU2624901C2 (en) 2015-10-05 2015-10-05 Agent for application anaesthesia with antiseptic, optical-keratoprotective properties and method for use thereof in ophthalmology

Publications (2)

Publication Number Publication Date
RU2015142156A true RU2015142156A (en) 2017-04-10
RU2624901C2 RU2624901C2 (en) 2017-07-07

Family

ID=58505832

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015142156A RU2624901C2 (en) 2015-10-05 2015-10-05 Agent for application anaesthesia with antiseptic, optical-keratoprotective properties and method for use thereof in ophthalmology

Country Status (1)

Country Link
RU (1) RU2624901C2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2038076C1 (en) * 1992-11-16 1995-06-27 Леонидов Николай Борисович Local anesthetic ophthalmic remedy
RU2180557C2 (en) * 1998-06-26 2002-03-20 Казахский Государственный национальный университет им. Аль-Фараби Anesthetic composition with prolonged effect
RU2147876C1 (en) * 1999-07-08 2000-04-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Pharmaceutical composition for anesthesia in ophthalmology
RU2262925C2 (en) * 2003-07-23 2005-10-27 Высоков Виктор Игоревич Gel-like preparation for local anesthesia
RU2542089C2 (en) * 2013-03-28 2015-02-20 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Method for pain management accompanying keratoconus treatment by cross-linking technique
CN103393714B (en) * 2013-08-20 2015-08-26 李赴朝 Local anaesthetics pain relieving delay agent
ES2540151B1 (en) * 2013-10-11 2016-02-29 Farmalider S.A. Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use

Also Published As

Publication number Publication date
RU2624901C2 (en) 2017-07-07

Similar Documents

Publication Publication Date Title
PH12020551766A1 (en) Use of pilocarpine hydrochloride for the treatment of ocular conditions
MX2023003124A (en) Ophthalmic pharmaceutical compositions and uses relating thereto.
JP2014533274A5 (en)
WO2015056096A3 (en) Method and apparatus for trabeculectomy and suprachoroidal shunt surgery
WO2011053768A3 (en) System and method for stabilizing corneal tissue after treatment
WO2018022437A3 (en) Multikinase inhibitors and uses in ocular fibrosis
CN103068364A (en) Preservative free bimatoprost and timolol solutions
IL273531A (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
MX2022001069A (en) Compositions and methods for treatment of presbyopia.
WO2015094019A3 (en) Pharmaceutical preparation for preventing and treating progressive myopia
EA201001326A1 (en) STERILE OPHTHALMOLOGICAL COMPOSITIONS AND METHOD FOR THEIR PRODUCTION
EA201891730A1 (en) OPHTHALMOLOGICAL COMPOSITION FOR APPLICATION IN THE TREATMENT OF OPHTHALMOLOGICAL DISORDERS RELATED TO CHANGES OF CORNER-CONJUNCTIVE SURFACE
RU2015142156A (en) Means for application anesthesia with antiseptic, opticokeratoprotective properties and method of its use in ophthalmology
MX2022000928A (en) Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions.
WO2017152129A3 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
MX2020012011A (en) Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension.
EA201690903A1 (en) TREATMENT GLAUCOMA USING LAQUINIMODE
EP3860592A4 (en) Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases
WO2019090010A3 (en) Composition for treating ocular disorders such as macular degeneration, retinopathy and glaucoma
RU2018107321A (en) A method for the surgical treatment of mild myopia
Wen Efficacy of internal limiting membrane peeling and vitrectomy with triamcinolone acetonide and silicone oil tamponade for the treatment of retinal detachment with choroidal detachment attributable to macular hole in high myopia
AR106690A1 (en) METHOD FOR ADMINISTRATING SCUALAMINE OR A PHARMACEUTICALLY ACCEPTABLE SALT TO THE BACK SCLERORICS AND THE EYE COROIDS
EP3970751C0 (en) Ophthalmic composition for the treatment of corneal edema
PH12020551418A1 (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor
RU2020134432A (en) METHODS FOR THE TREATMENT OF PRESBYOPIA

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20171006